MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GALLA, H. J.
Right arrow Articles by TRUDELL, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GALLA, H. J.
Right arrow Articles by TRUDELL, J. R.

Molecular Pharmacology, Vol 19, 432-437, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Perturbation of Peptide-Induced Lateral Phase Separations in Phosphatidic Acid Bilayers by the Inhalation Anesthetic Methoxyflurane

H. J. GALLA 1 and J. R. TRUDELL 1

1 Department of Anesthesia, Stanford University School of Medicine, Stanford, California 94305

The effect of methoxyflurane in a clinical concentration range on a phospholipid-peptide interaction in model membranes was studied by electron paramagnetic resonance. Thermotropic phase transition curves of negatively charged phosphatidic acid bilayers in the presence of the peptide antibiotic polymyxin-B were obtained using the spin probe 2,2,6,6-tetramethylpiperidine-1-oxyl. Polymyxin interacts strongly with phosphatidic acid membranes, causing lateral phase separations. Domains of peptide-bound phospholipids are formed in a matrix of a bilayer of unbound phosphatidic acid. The phase transition of the polymyxin-phosphatidic acid domain is decreased by about 13° as compared with a pure phosphatidic acid bilayer. The phosphatidic acid matrix surrounding these domains exhibits a somewhat broadened and lowered phase transition due to the presence of some monomeric polymyxin. Addition of the inhalation anesthetic methoxyflurane progressively disrupts the polymyxin-induced lateral phase separation, leading to a homogeneously dispersed phase at concentrations above 100 mmoles of anesthetic per mole of lipid. Application of high pressure antagonizes the effect of the anesthetic on the phase transition temperature of the free phosphatidic acid matrix and antagonizes the disruption of the phosphatidic acid-polymyxin domain. In a phosphatidic acid bilayer containing polymyxin, 4 moles %, a pressure of 100 atmos absolute (ATA) antagonizes the effect of 30 mmoles of methoxyflurane per mole of lipid. The latter concentration is equal to that produced in nerve membranes during clinical anesthesia, while a pressure of 100 ATA is sufficient to reverse anesthesia in mice and tadpoles. A much larger antagonism of the pressure and inhalation anesthetic effects is observed in the phase transition temperature of the surrounding phosphatidic acid phase than in the polymyxin-phosphatidic acid domains. However, at methoxyflurane concentrations greater than 100 mmoles/mole of lipid, when the polymyxin-phosphatidic acid domains are completely dispersed and form a homogeneous bilayer structure, the effect of pressure is only 20% of that observed in a pure phosphatidic acid vesicle containing the same concentration of methoxyflurane.

Submitted on September 4, 1980
Accepted on December 31, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics